ClinicalTrials.Veeva

Menu

Physiologic Change of Posterior Ocular Segment During Pregnancy

K

Khon Kaen University

Status

Not yet enrolling

Conditions

Retinal Vascular

Treatments

Device: Optical coherence tomography and optical coherence tomography angiography (Optovue®)

Study type

Interventional

Funder types

Other

Identifiers

NCT04731415
HE631577

Details and patient eligibility

About

Women's physiology changes markedly during normal pregnancy. The most distinct alterations occur in the hormonal and cardiovascular systems. There is a dramatic increase in both estrogen and progesterone. Blood volume starts to increase in the first gestational period and reaches a peak in the third trimester.

The physiologic ocular changes during pregnancy are mainly the result of hormonal and blood volume increase, and then are usually marked in the third trimester.

Full description

Ocular anterior segment changes during pregnancy are the followings

  • Melanogenesis of eyelid and facial skin -> melasma
  • Cellular alteration of lacrimal and meibomian gland -> dry eye symptoms
  • Increased corneal thickness and corneal curvature -> contact lens intolerance
  • Increased lens thickness -> loss of accommodation
  • Decreased intraocular pressure -> better glaucoma control There are few studies of posterior changes in pregnant women. Many limitations of previous publications includes lack of internal control and no data of postpartum contraception. However, choroidal thickness seems to be thicker in pregnant women than non-pregnant women. The other changes are non-inclusive.

Enrollment

69 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy pregnant women
  • Age > 18 years
  • Gestational age < 12 weeks
  • Written informed consent

Exclusion criteria

  • High risk pregnancy such as multifetal pregnancy and preeclampsia
  • History of vitreoretinal diseases such as retinal vasculitis
  • History of intraocular laser treatments or intraocular surgeries
  • History of systemic diseases such as diabetes mellitus and thyroid disease
  • Refractive error; spherical equivalence > 4 diopters
  • Clear ocular media
  • Could not be taken the images by non-dilated pupil

Withdrawal Criteria:

  • Preterm labor; gestational age < 34 weeks
  • Multifetal pregnancy was demonstrated by ultrasound
  • Severe labor and delivery complications such as
  • Severe postpartum complications such as postpartum bleeding
  • Taking hormone during the follow-up period

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

69 participants in 1 patient group

Healthy pregnant women
Other group
Description:
Optical coherence tomography and Optical coherence tomography angiography using Optovue® were performed in each trimester and at 6 weeks after childbirth.
Treatment:
Device: Optical coherence tomography and optical coherence tomography angiography (Optovue®)

Trial contacts and locations

1

Loading...

Central trial contact

Suthasinee Sinawat, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems